Silo Pharma SILO Institutional Ownership

Ownership Summary

Silo Pharma, Inc. (NASDAQ:SILO) has 15 institutional investors that have filed 13F reports for the period ending March 2026.

• They owned 7.7% of outstanding stock in March 2026, down from 14.5% the prior quarter.
• They increased total shares held in Silo Pharma by 27.07% from last quarter, and the number of investors in SILO increased 7.14% annually.
• Activity in SILO broke down as 10 buyers, 3 sellers, and 2 unchanged among 15 total holders.
• Altogether, these fund groups held 70.39K shares in SILO by March 2026, up by 14.99K shares quarter on quarter, and up 53.82K shares year over year.
• AdvisorShares Investments LLC is the top holder of Silo Pharma as of March 31, 2026, with 44.26K shares representing 4.84% of outstanding stock.
• The most significant purchases of SILO for the quarter ending March 2026 came from GEODE CAPITAL MANAGEMENT, LLC (5.81K), AdvisorShares Investments LLC (4.3K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2.21K), CITADEL ADVISORS LLC (1.43K), TWO SIGMA SECURITIES, LLC (966).
• The largest sellers of Silo Pharma for the quarter ending March 2026 were XTX Topco Ltd (2.65K), Citigroup Inc (230), Tower Research Capital LLC (TRC) (1).
• Per Business Quant, the top 10 investors in SILO for the quarter ending March 2026 include AdvisorShares Investments LLC (44.26K), GEODE CAPITAL MANAGEMENT, LLC (12.0K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (4.19K), JANE STREET GROUP, LLC (2.98K), CITADEL ADVISORS LLC (1.43K), XTX Topco Ltd (1.14K), TWO SIGMA SECURITIES, LLC (966), VANGUARD FIDUCIARY TRUST CO (873), LPL Financial LLC (835), State Street Corp (833).